Who invested in Capital Rx?
Capital Rx's investors include General Catalyst, Wellington Management and Edison Partners. General Catalyst led its latest round.

United States · Series F startup
2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Capital Rx and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$264Mraised across 2 rounds since 2019, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by AlleyWatchSEC filing: $231M sold, first sale Aug 2025
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Capital Rx's investors include General Catalyst, Wellington Management and Edison Partners. General Catalyst led its latest round.
Capital Rx has raised $264M across 2 rounds since 2019.
Capital Rx's most recent round was a Series F of $252M in Sept 2025, led by General Catalyst.
Its most recent round, $252M in Sept 2025, is also its largest on record.
Capital Rx's first round on record, in Jul 2019, was backed by Edison Partners.
Capital Rx's latest named round is a Series F, in Sept 2025.
Capital Rx is based in the United States.
General Catalyst led the Series F in 2025.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.